Evidence map›Paper›PMID 36107773›Full record

ArticleNucleic acids research2022

Global 5'-UTR RNA structure regulates translation of a SERPINA1 mRNA.

Philip J Grayeski, Chase A Weidmann, Jayashree Kumar, Lela Lackey, Anthony M Mustoe, Steven Busan, Alain Laederach, Kevin M Weeks

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. A New Class of Pathogenic Non-Coding Variants in GLA.International journal of molecular sciences · 2026
    Article
  4. Review
  5. Article
  6. The strategies and advances of mRNA translation booster.Asian journal of pharmaceutical sciences · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Testing Alpha-1 Antitrypsin Deficiency in Black Populations.Advances in respiratory medicine · 2023
    Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Philip J GrayeskiDepartment of Chemistry, University of North Carolina, Chapel Hill, NC 27599-3290, USA.
Chase A WeidmannDepartment of Biological Chemistry, Center for RNA Biomedicine, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Jayashree KumarDepartment of Biology, University of North Carolina, Chapel Hill, NC 27599, USA.
Lela LackeyDepartment of Genetics and Biochemistry, Center for Human Genetics, Clemson University, Greenwood, SC 29646, USA.
Anthony M MustoeVerna and Marrs McClean Department of Biochemistry and Molecular Biology, Department of Molecular and Human Genetics, and Therapeutic Innovation Center (THINC), Baylor College of Medicine, Houston, TX 77030, USA.
Steven BusanDepartment of Chemistry, University of North Carolina, Chapel Hill, NC 27599-3290, USA.
Alain LaederachDepartment of Biology, University of North Carolina, Chapel Hill, NC 27599, USA.ORCID 0000-0002-5088-9907
Kevin M WeeksDepartment of Chemistry, University of North Carolina, Chapel Hill, NC 27599-3290, USA.ORCID 0000-0002-6748-9985
University of North Carolina at Chapel Hill · USBaylor College of Medicine · USCenter for Human Genetics · USUniversity of Michigan · US

Funding

Non-coding RNA structure change in Chronic Obstructive Pulmonary DiseaseR01HL111527 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Alain T Laederach, Kevin M Weeks · 2012 to 2026
$6.6M
Variant induced RNA structure change in human genetic diseaseR35GM140844 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LAEDERACH, ALAIN T · 2021 to 2025
$2.1M
Pre-mRNA intronic structures in trans factor binding and alternative splicingR35GM142851 · NIGMS · CLEMSON UNIVERSITY · PI LACKEY, LELA LYNN · 2021 to 2025
$1.8M
Unraveling the MALAT1 lncRNA-protein interaction networks that drive lung cancer metastasisK22CA262349 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WEIDMANN, CHASE A · 2021 to 2023
$486k
Structural Analysis of SERPINA1 RNA in A1AT DeficiencyF30HL146174 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI GRAYESKI, PHILIP JOSEPH · 2019 to 2020
$73k
NCI NIH HHS K22 CA262349NHLBI NIH HHS F30 HL146174NHLBI NIH HHS R01 HL111527NIGMS NIH HHS R35 GM140844NIGMS NIH HHS R35 GM142851
6 · The paper itself

Abstract

SERPINA1 mRNAs encode the protease inhibitor α-1-antitrypsin and are regulated through post-transcriptional mechanisms. α-1-antitrypsin deficiency leads to chronic obstructive pulmonary disease (COPD) and liver cirrhosis, and specific variants in the 5'-untranslated region (5'-UTR) are associated with COPD. The NM_000295.4 transcript is well expressed and translated in lung and blood and features an extended 5'-UTR that does not contain a competing upstream open reading frame (uORF). We show that the 5'-UTR of NM_000295.4 folds into a well-defined multi-helix structural domain. We systematically destabilized mRNA structure across the NM_000295.4 5'-UTR, and measured changes in (SHAPE quantified) RNA structure and cap-dependent translation relative to a native-sequence reporter. Surprisingly, despite destabilizing local RNA structure, most mutations either had no effect on or decreased translation. Most structure-destabilizing mutations retained native, global 5'-UTR structure. However, those mutations that disrupted the helix that anchors the 5'-UTR domain yielded three groups of non-native structures. Two of these non-native structure groups refolded to create a stable helix near the translation initiation site that decreases translation. Thus, in contrast to the conventional model that RNA structure in 5'-UTRs primarily inhibits translation, complex folding of the NM_000295.4 5'-UTR creates a translation-optimized message by promoting accessibility at the translation initiation site.

Indexed as

Protein BiosynthesisPulmonary Disease, Chronic Obstructive5' Untranslated Regionsalpha 1-AntitrypsinHumansProtease InhibitorsRNA, Messenger5' Untranslated Regionsalpha 1-AntitrypsinProtease InhibitorsRNA, MessengerSERPINA1 protein, human

Identifiers

PMID36107773
PMCPMC9508835
OpenAlexW4295893217

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.